Category: Parkinsons

LMU-294

LMU 294 – Protecting Against Parkinson’s: The Role of Glutathione

Protecting Against Parkinson’s: The Role of Glutathione and AgingSource: International Journal of Molecular Science (2021)Lifestyle Medicine Update (July 5, 2023)Parkinson’s Disease – A Growing ConcernParkinson’s disease, the second most common neurodegenerative condition after Alzheimer’s, affects one in five hundredadults over fifty. By the year 2030, approximately nine million people are estimated to be afflicted with Read More

LMU-289

LMU 289 – NAC Administration Improves Parkinson’s Disease: The importance of preventing the age-related decline in brain glutathione

NAC Administration Improves Parkinson’s Disease: The importance of preventing the age-related decline in brain glutathioneSource: J Clinical Pharmacology & Therapeutics (2019)Lifestyle Medicine Update (November 15, 2022)As outlined in the 2021 review paper in the International Journal of Molecular Science, entitled Glutathione in the Brain (Aoyama K), a decline in brain glutathione levels in the aging Read More

LMU-267

LMU 267 – Metformin Shown to Double Risk of Dementia and Parkinson’s Disease in Large, 12-year Study with Type 2 Diabetics

Metformin Shown to Double Risk of Dementia and Parkinson’s Disease in Large, 12-year Study with Type 2 DiabeticsSource: 13th International Conference on Alzheimer’s and Parkinson’s disease (Abstract 312), presented on March 29, 2017, and reviewed in the December 5, 2022, Medscape ArticleLifestyle Medicine Update (December 6, 2022)A very popular drug in the management of type Read More